PANACEABIO — Panacea Biotec Balance Sheet
0.000.00%
- IN₹32.91bn
- IN₹31.06bn
- IN₹5.59bn
Annual balance sheet for Panacea Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 898 | 1,487 | 5,493 | 2,075 | 1,514 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,048 | 867 | 1,338 | 1,096 | 1,114 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,833 | 5,110 | 9,906 | 5,683 | 4,852 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,650 | 6,279 | 6,255 | 6,163 | 6,348 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,903 | 11,775 | 17,589 | 12,712 | 12,407 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,552 | 4,491 | 7,764 | 3,318 | 3,088 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,915 | 14,062 | 8,822 | 4,276 | 3,986 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1,988 | -2,287 | 8,766 | 8,436 | 8,420 |
Total Liabilities & Shareholders' Equity | 13,903 | 11,775 | 17,589 | 12,712 | 12,407 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |